Your browser doesn't support javascript.
loading
Advances of Angiopoietin-Tie axis in vascular and lymphatic system-related diseases / 生物工程学报
Chinese Journal of Biotechnology ; (12): 2633-2644, 2021.
Article in Chinese | WPRIM | ID: wpr-887829
ABSTRACT
Endothelial cells that form the inner layers of both blood and lymphatic vessels are important components of the vascular system and are involved in the pathogenesis of vascular and lymphatic diseases. Angiopoietin (Ang)-Tie axis in endothelial cells is the second endothelium-specific ligand-receptor signaling system necessary for embryonic cardiovascular and lymphatic development in addition to the vascular endothelial growth factor receptor pathway. The Ang-Tie axis also maintains vascular homeostasis by regulating postnatal angiogenesis, vessel remodeling, vascular permeability, and inflammation. Therefore, the dysfunction of this system leads to many vascular and lymphatic diseases. In light of the recent advances on the role of the Ang-Tie axis in vascular and lymphatic system-related diseases, this review summarizes the functions of the Ang-Tie axis in inflammation-induced vascular permeability, vascular remodeling, ocular angiogenesis, shear stress response, atherosclerosis, tumor angiogenesis, and metastasis. Moreover, this review summarizes the relevant therapeutic antibodies, recombinant proteins, and small molecular drugs associated with the Ang-Tie axis.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Signal Transduction / Endothelial Cells / Receptor, TIE-2 / Angiopoietins / Vascular Endothelial Growth Factor A / Lymphatic Diseases / Lymphatic System Limits: Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Signal Transduction / Endothelial Cells / Receptor, TIE-2 / Angiopoietins / Vascular Endothelial Growth Factor A / Lymphatic Diseases / Lymphatic System Limits: Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2021 Type: Article